Skip to main content

Table 2 The effect of TRPA1 antagonist 3 μg A-967079 on cystometry parameters of inflammatory rats

From: Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition

       Compliance (μl/mmHg) N-VC (number)
   BP (mmHg) PT (mmHg) MP (mmHg) ICI (min)
  No-treatment 11.83 ± 2.96 12.74 ± 3.4 21.76 ± 1.63 4.80 ± 1.79 91.44 ± 18.19 0.25 ± 0.5
Control Treatment 11.66 ± 3.32 12.42 ± 3.83 20.82 ± 2.84 4.76 ± 1.96 92.88 ± 43.76 0
  Recovery 11.71 ± 3.19 12.73 ± 3.83 21.19 ± 2.22 4.68 ± 1.68 104.56 ± 40.19 0
  No-treatment 10.54 ± 3.23 11.94 ± 2.88 22.68 ± 4.89 3.64 ± 0.78 80.07 ± 27.31 3.00 ± 0.82
Cystitis Treatment 10.25 ± 3.99 12.00 ± 4.67 22.68 ± 5.28 5.87 ± 0.93* 67.40 ± 7.66 0.75 ± 0.50**
  Recovery 9.85 ± 4.37 11.46 ± 4.75 21.96 ± 5.75 4.50 ± 1.59 90.86 ± 34.91 1.25 ± 0.50*
  1. Results were expressed as mean ± standard error. The “*” or “**” represented the difference was significant between the treatment or recovery and no-treatment in cystometry parameters. *P < 0.05, ** P < 0.01